The Valley Desk

NCT01637961 · Interventional trial

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Overall registry status Completed

Phase 2

Conditions Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov